Lv4
450 积分 2024-08-28 加入
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization
27天前
已完结
Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis
3个月前
已完结
Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver Disease
3个月前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
3个月前
已完结
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
3个月前
已完结
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
4个月前
已完结
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
7个月前
已完结
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
7个月前
已关闭
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
7个月前
已关闭
皖公网安备34019202002308
